Coverage of side-effects experienced from GLP-1 drugs like Ozempic, Wegovy and Mounjaro
Explore how to manage Ozempic’s common side effects like diarrhea. Learn practical tips for dietary adjustments, hydration, and when to consult your healthcare provider for a smoother journey.
Enjoying coffee while taking Ozempic? Learn how it can slow digestion making caffeine last longer, and tips to limit side effects like nausea and stomach upset.
Get 7 practical tips to beat that Ozempic nausea so you can stick with it and see the amazing results.
Learn how to manage constipation caused by Ozempic through dietary changes, lifestyle adjustments, and potential medical interventions in our comprehensive guide.
Tired from Ozempic? Learn how to combat fatigue with simple lifestyle changes and expert advice. Stay hydrated, adjust your diet, and fine-tune your exercise routine to keep your energy up.
To date, there have been no reported cases associating GLP-1 agonists with rhabdomyolysis, making this revelation a significant milestone in medical research.
The first evidence of semaglutide’s specific efficacy in alleviating symptoms of Alcohol Use Disorder (AUD) has been published in The Journal of Clinical Psychiatry.
Pfizer has decided to halt the advancement of danuglipron following a challenging Phase 2b clinical trial, primarily the high incidence of adverse side effects.
The European Medicines Agency (EMA) is scrutinizing of Ozempic and Wegovy for possible links to suicidal thoughts. The investigation was spurred by reports from the Icelandic Medicines Agency and EudraVigilance.
While GLP-1 agonists are known for their effective weight loss results, they come with significant drawbacks, including loss of lean muscle mass. Taldefgrobep alfa, a myostatin inhibitor licensed from Bristol Myers Squibb, stands apart by targeting not just fat loss but also muscle preservation.
